Cargando…
Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report
We describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969541/ https://www.ncbi.nlm.nih.gov/pubmed/36860723 http://dx.doi.org/10.1002/ccr3.6012 |